In vivo and in vitro Epstein-Barr virus associated lymphoproliferative disorders;Lymphoproliferations T associees au virus d'Epstein-Barr

Medecine/Sciences

Volumn 14, Issue 6-7, 1998, Pages 690-697

  Montpellier, Claire ^a   Groux, Hervé ^a   Auriault, Claude ^a   Coll, Jean ^a  

^a INSTITUT DE BIOLOGIE DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; EPSTEIN BARR VIRUS; HODGKIN DISEASE; HUMAN; INFECTIOUS MONONUCLEOSIS; LYMPHOBLAST; LYMPHOCYTE TRANSFORMATION; LYMPHOPROLIFERATIVE DISEASE; NASOPHARYNX CARCINOMA; NONHODGKIN LYMPHOMA; NONHUMAN; T CELL LYMPHOMA; T LYMPHOCYTE;

HUMAN HERPESVIRUS 4;

EID: 0031871621     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/1123     Document Type: Article

References (45)

1. Marelle L, Rea D, Raphaël M. Le vírus d'Epstein-Barr et les proliférations lymphoides. Med Sci 1993; 9: 693-700.
2. Epstein M, Achong B, Barr Y. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964; 1: 702-3.
3. Kikuta H, Taguchi Y, Tormizawa K, Kojima K, Kawamura N, Ishizaka A, et al. Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 1988; 333: 455-7.
4. Jones JF, Shurin S, Abramowsky C, Tubbs RR, Sciotto CG, Wahl R, Sands J, Gottman D, Katz BZ, Sklar J. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 1988; 318: 733-41.
5. Iinai S, Sugiura M, Oikawa O, Koizumi S, Hirao M, Kimura H, et al. Epstein-Barr virus (EBV)-carrying and expressing T-cell lines established from severe chronic active EBV infection. Blood 1996; 87: 1448-57.
6. Su IJ, Chen RL, Lin DT, Lin KS, Chen CC. Epstein-Barr virus infects T lymphocytes in childhood EBV-associated haemophagocytic syndrome in Taïwan. Am J Pathol 1994; 144: 1219-25.
7. Kawaguchi H, Miyashita T, Herbst H, Niedobitek G, Asada M, et al. Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated haemophagocytic syndrome. J Clin Invest 1993; 92: 1444-50.
8. + T cells. Leukaemia 1992; 6: 952-6.
9. Craig FE, Clare CN, Sklar JL, Banks PM. T cell lymphoma and the virus associated haemophagocytic syndrome. Am J Clin Path 1992; 97: 189-94.
10. Gaillard F, Mechinaud-Lacroix F, Papin S, Moreau A, Mollat C, et al. Primary Epstein-Barr virus infection with clonal T-cell lymphoproliferation. Am J Clin Path 1992; 98: 324-33.
11. Harabuchi Y, Yamanaka N, Kataura A, Imai S, Kinoshita T, Mizuno F, Osato T, et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal mid-line granuloma. Lancet 1990; 335: 128-30.
12. Pallesen G, Hamilton-Dutoit SJ, Shou X. The association of Epstein-Barr virus (EBV) with T cell lymphoproliferations and Hodgkin's disease : two new developments in the EBV field. Adv Cancer Res 1993; 62: 179-239.
13. Su IJ, Hsieh HC, Lin KH, Uen WC, Kao CL, Chen CJ, Cheng AL, Kadin ME, Chen JY. Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA. A clinicopathological and molecular analysis. Blood 1991; 77: 799-808.
14. Zhou XG, Hamilton-Dutoit SJ, Yan QH, Pallesen G. High frequency of Epstein-Barr virus in Chinese peripheral T cell lymphoma. Histopathology 1994; 24: 115-22.
15. De Bruin PC, Jiwa M, Oudejans JJ, van der Valk P, van Heerde P, Sabourin JC, et al. Presence of Epstein-Barr virus in extranodal T-cell Iymphomas : differences in relation to site. Blood 1994; 83: 1612-8.
16. Meijer CJ, Jiwa NM, Dukers DF, Oudejans JJ, de Bruin PC, Walboomers JM, van den Brule AJ. Epstein-Barr virus and human T-cell lymphomas. Semin Cancer Biol 1996; 7: 191-6.
17. Chiang AK, Chan AC, Srivastava G, Ho FC. Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage. Int J Cancer 1997; 73: 332-8.
18. Minarovits J, Hu LF, Imai S, Harabuchi Y, Kataura A, et al. Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classifed as peripheral angiocentric T cell lymphomas. J Gen Virol 1994; 75: 77-84.
19. d'Amore F, Johansen P, Houmand A, Weisenburger DD, Mortensen LS. Epstein-Barr virus genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lympnoma and correlation with a poor prognosis. Blood 1996; 87: 1045-55.
20. Chen CL, Sadler RH, Walling DM, Su IJ, Hsieh HC, Raab-Traub N. Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T cell lymphomas. J Virol 1993; 67: 6303-8.
21. Suzushima H, Asou N, Fujimoto T, Nishimura S, Okubo T, Yamasaki H. Lack of the expression of EBNA-2 and LMP-1 in T-cell neoplasms possessing Epstein-Barr virus. Blood 1995; 85: 480-6.
22. Wen S, Mizugaki Y, Shinozaki F, Takada K. Epstein-Barr virus (EBV) infection in salivary gland tumors: lytic EBV infection in nonmalignant epithelial cells surrounded by EBV-positive T-lymphoma cells. Virology 1997; 227: 484-7.
23. Thomas JA, Cotter F, Hanby AM, Long LQ, Morgan PR, Bramble B, Bailey BM. Epstein-Barr virus-related oral T-cell lympnoma associated with human imunodeficiency virus immunosuppression. Blood 1993; 81 : 3350-6.
24. Tokunaga M, Imai S, Uemura M, Tokudome T, Osato T, Sato E. Epstein-Barr virus in adult T-cell leukemia/lymphoma. Am J Pathol 1993; 143: 1263-9.
25. Toben HR, Smith RG. T lymphocytes bearing complement receptors in a patient with chronic lymphocytic leukaemia. Clin Exp Immunol 1977; 27: 292-302.
26. Fischer E, Delibrias C, Kazatchkine MD. Expression of CR2 (the C3dg/EBV receptor, CD 21) on normal human peripheral blood T Iymphocytes. J Immunol 1991; 146: 865-9.
27. Tsoukas CD, Lambris JD. Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies. Eur J Immunol 1988; 18: 1229-302.
28. Watry D, Hedrick JA, Siervo S, Rhodes G, Lamberti JJ, Lambris JD, Tsoukas CD. Infection of human thymocytes by Epstein-Barr virus. J Exp Med 1991; 173: 971-80.
29. Fingeroth JD, Clabby ML, Strominger JD. Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21). J Virol 1988; 62: 1442-7.
30. Yoshiyama H, Imai S, Shimizu N, Takada K. Epstein-Barr virus infection of human gastric carcinoma cells : implication of the existence of a new virus receptor different from CD21. J Virol 1997; 71: 5688-91.
31. Kelleher CA, Kaufman Paterson R, Dreyfus DH, Streib JE, Wu JW, Takase K, Jones JF, Gelfand EW. Epstein-Barr virus replicative gene transcription during de novo infection of human thymocytes: simultaneous early expression of BZLF-1 and its represser RAZ. Virology 1995; 208: 685-95.
32. Kaufman Paterson RL, Kelleher CA, Streib JE, Amankonah TD, Wu XJ, Jones JF, Gelfland EW. Activation of human thymocytes after infection by EBV. J Immunol 1995; 154: 1440-9.
33. + T lymphocytes by Epstein-Barr virus enhances human immunodeficiency virus expression. J Virol 1996; 70: 7341-6.
34. Raphaël M, Eclache V, Martin A, Feuillard J. Les lymphomes du SIDA. Med Sci 1995; 11: 713-22.
35. Hedrick JA, Watry D, Speiser C, O'Donnell P, Lambris JD, Tsoukas CD. Interaction between Epstein-Barr virus and a T cell line (HSB-2) via a receptor phenotypically distinct from complement receptor type 2. Eur J Immunol 1992; 22: 1123-31.
36. Shapiro IM, Volsky DJ, Saemundsen AK. Infection of the human T-cell-derived leukemia line Molt-4 by Epstein-Barr virus (EBV) : induction of EBV-determined antigens and virus reproduction. Virology 1982; 120: 171-81.
37. Fujiwara S, Ono Y. Isolation of Epstein-Barr virus-infected clones of the human T-cell line MT-2 : use of recombinant viruses with a positive selection marker. J Virol 1995; 69: 3900-3.
38. Yoshiyama H, Shimizu N, Takada K. Persistent Epstein-Barr virus infection in a human T-cell line: unique program of latent virus expression. EMBO J 1995; 14: 3706-11.
39. Peng M, Lundgren E. Transient expression of the Epstein-Barr virus LMP1 gene in B-cell chronic lymphocytic leukemia cells, T cells, and hematopoietic cell lines: cell-type-independent-induction of CD23, CD21, and ICAM-1. Leukemia 1993; 7: 104-12.
40. Kawanishi M. Expression of Epstein-Barr virus latent membrane protein 1 protects Jurkat T cells from apoptosis induced by serum deprivation. Virology 1997; 228: 244-50.
41. Stevenson M, Volsky B, Hedenskog M, Volsky DJ. Immortalization of human T lymphocytes after transfection of Epstein-Barr vires DNA. Science 1986; 233: 980-4.
42. Groux H, Cottrez F, Montpellier C, Quattanens B, Coll J, Stéhelin D, Auriault C. Isolation and characterization of transformed human T-cell lines infected by Epstein-Barr virus. Blood 1997; 89: 4521-30.
43. Montpellier C, Crepieux P, Quatannens B, Delobel B, Croquette MF, Stéhelin D, Auriault C, Groux H, Coll J. Homologous T and B cells immortalized in vitro by the Epstein-Barr virus exhibit differential genetical and functional features. Int J Oncol 1997; 11: 87-96.
44. Stancovski I, Baltimore D. NF-κB activation: the 1κB kinase revealed? Cell 1997; 91: 299-302.
45. Kieser A, Kilger E, Gires O, Ueffing M, Kolch W, Hammerschmidt W. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. EMBO J 1997; 16: 6478-85.